TPT0201

N/A

Report date: 2025/07/18 16:10:50
NME

Base Information

Drug NameTPT0201
Drug Alias NameTPT0201TPT-0201
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionMonoglyceride lipase inhibitorsAnandamide amidohydrolase inhibitors
TargetsMonoglyceride lipaseAnandamide amidohydrolase
Therapy Area/IndicationsCognitive DysfunctionAlzheimer Disease
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryDenmark
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesTetra Pharm Technologies ApS
China Registration ClassN/A

Develop Information

Active CompaniesTetra Pharm Technologies ApS
Inactive CompaniesN/A
Active IndicationsCognitive DysfunctionAlzheimer Disease
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A